Osteogenic potential of the human bone morphogenetic protein 2 gene activated nanobone putty

被引:0
|
作者
TIAN XiaobinSUN LiYANG ShuhuaZHANG YukunHU Ruyin and FU Dehao Department of OrthopedicsPeoples Hospital of Guizhou ProvinceGuiyangGuizhou China Department of OrthopedicsAffiliated Union HospitalTongji Medical College of Huazhong Science and Technology University WuhanHubei China [550002 ,430022 ]
机构
关键词
D O I
暂无
中图分类号
R318.0 [一般性问题];
学科分类号
摘要
Background Nanobone putty is an injectable and bioresorbable bone substitute.The neutral-pH putty resembles hard bone tissue,does not contain polymers or plasticizers,and is self-setting and nearly isothermic,properties which are helpful for the adhesion,proliferation,and function of bone cells.The aim of this study was to investigate the osteogenic potential of human bone morphogenetic protein 2(hBMP2) gene activated nanobone putty in inducing ectopic bone formation,and the effects of the hBMP2 gene activated nanobone putty on repairing bone defects. Methods Twenty four Kunming mice were randomly divided into two groups.The nanobone putty+hBMP2 plasmid was injected into the right thigh muscle pouches of the mice(experiment side).The nanobone putty+blank plasmid or nanobone putty was injected into the left thigh muscle pouches of the group 1(control side 1) or group 2(control side 2), respectively.The effects of ectopic bone formation were evaluated by radiography,histology,and molecular biology analysis at 2 and 4 weeks after operation.Bilateral 15 mm radial defects were made in forty-eight rabbits.These rabbits were randomly divided into three groups:Group A,nanobone putty+hBMP2 plasmid;Group B,putty+blank plasmid; Group C,nanobone putty only.Six rabbits with left radial defects served as blank controls.The effect of bone repairing was evaluated by radiography,histology,molecular biology,and biomechanical analysis at 4,8,and 12 weeks after operation. Results The tissue from the experimental side of the mice expressed hBMP2.Obvious cartilage and island-distributed immature bone formation in implants of the experiment side were observed at 2 weeks after operation,and massive mature bone observed at 4 weeks.No bone formation was observed in the control side of the mice.The ALP activity in the experiment side of the mice was higher than that in the control side.The tissue of Group A rabbits expressed hBMP2 protein and higher ALP level.The new bone formation rate and antibending strength of group A was significantly higher than those of group B and C.The defects in blank control were not healed. Conclusions The hBMP2 gene activated nanobone putty exhibited osteoinductive ability,and had a better bone defect repair capability than that of nanobone putty only.
引用
收藏
页码:745 / 751
相关论文
共 50 条
  • [21] Expression of bone morphogenetic protein in the course of osteoinduction by recombinant human bone morphogenetic protein-2
    Okubo, Y
    Bessho, K
    Fujimura, K
    Kusumoto, K
    Ogawa, Y
    Iizuka, T
    CLINICAL ORAL IMPLANTS RESEARCH, 2002, 13 (01) : 80 - 85
  • [22] Effect of the Bone Morphogenetic Protein-2 Doses on the Osteogenic Potential of Human Multipotent Stromal Cells- Containing Tissue Engineered Constructs
    Decambron, Adeline
    Devriendt, Nausikaa
    Larochette, Nathanael
    Manassero, Mathieu
    Bourguignon, Marianne
    El-Hafci, Hanane
    Petite, Herve
    Viateau, Veronique
    Logeart-Avramoglou, Delphine
    TISSUE ENGINEERING PART A, 2019, 25 (7-8) : 642 - 651
  • [23] Limited but heterogeneous osteogenic response of human bone marrow mesenchymal stem cells to bone morphogenetic protein-2 and serum
    Mizuno, Daiki
    Agata, Hideki
    Furue, Hiroki
    Kimura, Ayuko
    Narita, Yuji
    Watanabe, Nobukazu
    Ishii, Yumiko
    Ueda, Minoru
    Tojo, Arinobu
    Kagami, Hideaki
    GROWTH FACTORS, 2010, 28 (01) : 34 - 43
  • [24] Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells
    Kim, DJ
    Moon, SH
    Kim, H
    Kwon, UH
    Park, MS
    Han, KJ
    Hahn, SB
    Lee, HM
    SPINE, 2003, 28 (24) : 2679 - 2684
  • [25] Recombinant human bone morphogenetic protein-2 potentiates the in vivo osteogenic ability of marrow/hydroxyapatite composites
    Noshi, T
    Yoshikawa, T
    Dohi, Y
    Ikeuchi, M
    Horiuchi, K
    Ichijima, K
    Sugimura, M
    Yonemasu, K
    Ohgushi, H
    ARTIFICIAL ORGANS, 2001, 25 (03) : 201 - 208
  • [26] Cloning and expression of human bone morphogenetic protein-2 gene in Leishmania tarentolae
    Rahmati, Majid
    Khan, Amjad Hayat
    Razavi, Shabnam
    Khorramizadeh, Mohammad Reza
    Rasaee, Mohammad Javad
    Sadroddiny, Esmaeil
    BIOCATALYSIS AND AGRICULTURAL BIOTECHNOLOGY, 2016, 5 : 199 - 203
  • [27] Pre-clinical evaluation of the osteogenic potential of bone morphogenetic protein-2 loaded onto a particulate porcine bone biomaterial
    Yon, Jeyoung
    Lee, Jung-Seok
    Lim, Hyun-Chang
    Kim, Min-Soo
    Hong, Ji-Youn
    Choi, Seong-Ho
    Jung, Ui-Won
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2015, 42 (01) : 81 - 88
  • [28] OSTEOGENIC ACTIVITY OF BONE MORPHOGENETIC PROTEIN AND HYDROXYAPATITE COMPOSITE IMPLANTS
    HERR, G
    WAHL, D
    KUSSWETTER, W
    ANNALES CHIRURGIAE ET GYNAECOLOGIAE, 1993, 82 : 99 - 107
  • [29] Comparison of the osteogenic activity of bone morphogenetic protein (BMP) mutants
    Depprich, R.
    Handschel, J.
    Sebald, W.
    Kuebler, N. R.
    Wuerzler, K. K.
    ORAL AND MAXILLOFACIAL SURGERY-HEIDELBERG, 2005, 9 (06): : 363 - 368
  • [30] Recombinant human bone morphogenetic protein-2
    Shaffrey, Christopher I.
    Smith, Justin S.
    JOURNAL OF NEUROSURGERY-SPINE, 2013, 18 (02) : 109 - 110